36 search results for: CRSwNP

Spotlight on Type 2 Inflammation in the Upper and Lower Airways
Pulmonology
Spotlight on Type 2 Inflammation in the Upper and Lower Airways
expert video

In this video soundbite from the EAACI 2025 symposium, Dr. Zuzana Diamant explains pathophysiological mechanisms underlying asthma and CRSwNP, and how type 2 inflammatory cytokines drive airway remodelling in patients with severe asthma. Additionally, patients with co-existing asthma and CRSwNP have a higher type 2 inflammatory burden than patients with asthma alone.

View more
ADVENT at ERS-ISIAN 2025
Congress
20
June
2025
Congress
ADVENT at ERS-ISIAN 2025

Join experts Vibeke Backer, MD, DMSC, and Sietze Reitsma, MD, at an educational symposium involving a comprehensive exploration of the type 2 inflammation and its pivotal role in the pathogenesis and management of CRSwNP.

Is 1 year an appropriate timeframe for deciding if a patient has achieved remission in <b>CRSwNP</b>?
Rhinology
Is 1 year an appropriate timeframe for deciding if a patient has achieved remission in CRSwNP?
expert video

Prof. Hellings and Prof. Corso explore the time frame to assess if the patient with CRSwNP has achieved remission

View more
What contributes more to loss of smell in patients with <b>CRSwNP</b>: nasal obstruction or inflammation?
Rhinology
What contributes more to loss of smell in patients with CRSwNP: nasal obstruction or inflammation?
expert video

Prof. Mullol discusses the contribution of nasal obstruction and inflammation in loss of smell in patients with CRSwNP

View more
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in <b>CRSwNP</b>
On Demand
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.

World Anosmia Awareness Day
On Demand
World Anosmia Awareness Day

Explore our educational resources about loss of smell and the role of type 2 inflammation in CRSwNP, featuring expert insights from Profs. Wytske Fokkens and Joaquim Mullol.

When is the right time to consider a biologic in patients with <b>CRSwNP</b>?
Rhinology
When is the right time to consider a biologic in patients with CRSwNP?
expert video

Prof. Hellings and Prof. Corso explain that the right time to implement a biologic depends on academic and reimbursement criteria, which vary by country.

View more
Dr. Giorgio Canonica Regarding Multidisciplinary Approach
Rhinology
Dr. Giorgio Canonica Regarding Multidisciplinary Approach
expert video

This video clip from the EAACI 2024 symposium highlights that a multidisciplinary approach is essential for the treatment of asthma.

View more
<b>CRSwNP</b> Interactive Patient Case Tool
Rhinology
CRSwNP Interactive Patient Case Tool
interactivity

Meet Fernando. Journey through his clinical profile, applying guideline-based checklists to reach a consensus regarding his diagnosis.

View more
How does a decrease in smell affect sleep disturbance? Is there any direct relation?
Rhinology
How does a decrease in smell affect sleep disturbance? Is there any direct relation?
expert video

Prof. Mullol share his opinion on connection between loss of smell and sleep disorder in patients with CRSwNP.

View more
How often do you suggest to assess sense of smell?
Rhinology
How often do you suggest to assess sense of smell?
expert video

Prof. Mullol highlights the utility of visual analog scale for quick assessment of sense of smell in patients with CRSwNP.

View more
EAACI 2024 | On-Treatment Clinical Remission in Upper and Lower Airways: ​ Going Beyond Symptom Control​
Congress
31
May
2024
Congress
EAACI 2024 | On-Treatment Clinical Remission in Upper and Lower Airways: ​ Going Beyond Symptom Control​

Join experts G. Walter Canonica, Vibeke Backer, and Joaquim Mullol for an educational symposium on elevating treatment goals from control to remission in the upper and lower airways.